K032796

Substantially Equivalent

IBL C3D-CIC EIA TEST

Applicant: Ibl GmbH
Product code: CZW
Advisory panel: Immunology
Date received: 2003-09-08
Decision date: 2004-01-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: East Stroudsburg, PA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.